Avita Medical’s RECELL Go wound-healing system is poised for 2026 as CMS payment issues ease. Read here for a detailed ...

Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...

Every day, Lockheed Martin delivers capabilities that strengthen and transform our world. On Tuesday night, the company's ninth GPS III space vehicle (SV09) launched in orbit, adding a capability that ...

GeekyAnts, a US-based IT consulting and development firm, has identified one consistent pattern while working on multiple projects and digital transformations: real users behave in ways that ...

In a case that reads like a mashup of Seabiscuit and Breaking Bad, a New Mexico judge stepped in last month to block the ...

Pam Kowalcyzk and her daughter have PKU, a rare disorder that prevents the body from processing protein ...

JCR Pharmaceuticals announced that it will present data at the 22nd Annual WORLDSymposium 2026, held February 2-6, 2026, in San Diego, Calif.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced ...

Geron Corporation (NASDAQ:GERN) advances cancer research as part of broader discussions linked to the nasdaq index.

Shares of Corvus Pharmaceuticals CRVS have skyrocketed 208.8% in a month. The massive stock price rally was observed after ...

A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that the company has been awarded the prestigious 2025 SwedenBIO Award. The ...